journal article·2023-02-09Open access

Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery

Hochung Jang, Hyosuk Kim, Eun Hye Kim, Geonhee Han, Yeongji Jang, Yelee Kim, Jong Won Lee, Sang Chul Shin, Eunice EunKyeong Kim, Sun Hwa Kim, Yoosoo Yang

Biomaterials Research· Volume 27· Issue 1

Abstract

Abstract Background Recently, increased attention has been given on exosomes as ideal nanocarriers of drugs owing to their intrinsic properties that facilitate the transport of biomolecular cargos. However, large-scale exosome production remains a major challenge in the clinical application of exosome-based drug delivery systems. Considering its biocompatibility and stability, bovine milk is a suitable natural source for large-scale and stable exosome production. Because the active-targeting ability of drug carriers is essential to maximize therapeutic efficacy and minimize side effects, precise membrane functionalization strategies are required to enable tissue-specific delivery of milk exosomes with difficulty in post-isolation modification. Methods In this study, the membrane functionalization of a milk exosome platform modified using a simple post-insertion method was examined comprehensively. Exosomes were engineered from bovine milk (mExo) with surface-tunable modifications for the delivery of tumor-targeting doxorubicin (Dox). The surface modification of mExo was achieved through the hydrophobic insertion of folate (FA)-conjugated lipids. Results We have confirmed the stable integration of functionalized PE-lipid chains into the mExo membrane through an optimized post-insertion technique, thereby effectively enhancing the surface functionality of mExo. Indeed, the results revealed that FA-modified mExo (mExo-FA) improved cellular uptake in cancer cells via FA receptor (FR)-mediated endocytosis. The designed mExo-FA selectively delivered Dox to FR-positive tumor cells and triggered notable tumor cell death, as confirmed by in vitro and in vivo analyses. Conclusions This simple and easy method for post-isolation modification of the exosomal surface may be used to develop milk-exosome-based drug delivery systems. Graphical Abstract
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · RNA Interference and Gene Delivery · Proteins in Food Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea.

Division of Bio-Medical Science and Technology, KIST School, University of Science and Technology, Seoul 02792, Republic of Korea.

Department of Life Sciences, Korea University, Seoul 02841, Republic of Korea.

KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Republic of Korea.

Technological Convergence Center, Research Resources Division, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea.

Funding

Ministry of Science and ICT, South Korea · Korea Institute of Science and Technology · KU-KIST Graduate School of Converging Science and Technology

References (50)

Show source-provided references
1. 10.1001/jamapediatrics.2015.102510.1001/jamapediatrics.2015.1025 ↗
2. 10.1111/apa.1315110.1111/apa.13151 ↗
3. Bener A, Ehlayel MS, Alsowaidi S, Sabbah A. Role of breast feeding in primary prevention of Asthma and allergic Diseases in a traditional society. Eur Ann Allergy Clin Immunol. 2007;39:337–43. 1:STN:280:DC%2BD1c3ivVWqtQ%3D%3D
4. 10.1038/s41598-017-06288-810.1038/s41598-017-06288-8 ↗
5. Kim H Jang H Cho H Choi J Hwang KY Choi Y Kim SH Yang Y. Recent advances in exosome-based drug delivery for Cancer Therapy. Cancers (Basel) 2021 13.10.3390/cancers13174435 ↗
6. 10.3390/ijms14071424010.3390/ijms140714240 ↗
7. He J Ren W Wang W Han W Jiang L Zhang D Guo M. Exosomal targeting and its potential clinical application. Drug Deliv Transl Res 2021.10.1007/s13346-021-01087-1 ↗
8. 10.3168/jds.2012-548910.3168/jds.2012-5489 ↗
9. 10.1021/acs.jafc.7b0312310.1021/acs.jafc.7b03123 ↗
10. Han G Kim H Kim DE Ahn Y Kim J Jang YJ Kim K Yang Y Kim SH. The Potential of Bovine Colostrum-Derived Exosomes to Repair Aged and Damaged Skin Cells. Pharmaceutics 2022 14.10.3390/pharmaceutics14020307 ↗
11. 10.1080/20013078.2018.144013110.1080/20013078.2018.1440131 ↗
12. Pullan J Dailey K Bhallamudi S Feng L Alhalhooly L Froberg J Osborn J Sarkar K Molden T Sathish V et al. Modified bovine milk exosomes for Doxorubicin Delivery to Triple-negative Breast Cancer cells. ACS Appl Bio Mater; 2022.10.1021/acsabm.2c00015 ↗
13. 10.1039/D0BM01497D10.1039/D0BM01497D ↗
14. 10.1016/j.jconrel.2016.01.00910.1016/j.jconrel.2016.01.009 ↗
15. 10.1016/j.bbagen.2020.12976310.1016/j.bbagen.2020.129763 ↗
16. 10.1016/j.nano.2017.09.01110.1016/j.nano.2017.09.011 ↗
17. 10.1016/j.bpj.2015.09.02210.1016/j.bpj.2015.09.022 ↗
18. 10.1186/s12951-018-0388-410.1186/s12951-018-0388-4 ↗
19. 10.1016/j.drup.2014.10.00210.1016/j.drup.2014.10.002 ↗
20. Zwicke GL Mansoori GA Jeffery CJ. Utilizing the folate receptor for active targeting of cancer nanotherapeutics. Nano Rev 2012 3.10.3402/nano.v3i0.18496 ↗
21. Zonneveld MI Brisson AR van Herwijnen MJ Tan S van de Lest CH Redegeld FA Garssen J Wauben MH. Nolte-‘t Hoen EN: Recovery of extracellular vesicles from human breast milk is influenced by sample collection and vesicle isolation procedures. J Extracell Vesicles 2014 3.10.3402/jev.v3.24215 ↗
22. 10.1038/srep4473510.1038/srep44735 ↗
23. 10.3389/fcell.2022.81520510.3389/fcell.2022.815205 ↗
24. Haugland RP, You WW. Coupling of antibodies with biotin. Methods Mol Biol. 2008;418:13–24. 1:CAS:528:DC%2BD1cXjsl2ks7c%3D
25. 10.1002/advs.20180085210.1002/advs.201800852 ↗
26. Matias R Ribeiro PRS Sarraguça MC Lopes JA. A UV spectrophotometric method for the determination of folic acid in pharmaceutical tablets and dissolution tests. Anal Methods 2014 6.10.1039/c3ay41874j ↗
27. 10.1016/j.ajps.2018.09.00410.1016/j.ajps.2018.09.004 ↗
28. 10.2147/IJN.S13584910.2147/IJN.S135849 ↗
29. 10.1038/s41467-021-24273-810.1038/s41467-021-24273-8 ↗
30. 10.1016/j.apsb.2021.12.01510.1016/j.apsb.2021.12.015 ↗
31. 10.1016/j.ejpb.2018.11.00110.1016/j.ejpb.2018.11.001 ↗
32. 10.2147/IJN.S21898810.2147/IJN.S218988 ↗
33. 10.1016/j.bbamem.2006.05.02810.1016/j.bbamem.2006.05.028 ↗
34. 10.1038/s41598-017-03284-w10.1038/s41598-017-03284-w ↗
35. 10.1007/BF0137255010.1007/BF01372550 ↗
36. 10.1152/ajpheart.00290.201810.1152/ajpheart.00290.2018 ↗
37. 10.1038/aps.2017.1210.1038/aps.2017.12 ↗
38. 10.1016/j.ejps.2016.10.00910.1016/j.ejps.2016.10.009 ↗
39. 10.1016/j.canlet.2015.10.02010.1016/j.canlet.2015.10.020 ↗
40. 10.1038/s41392-017-0004-310.1038/s41392-017-0004-3 ↗
41. Allen TM, Sapra P, Moase E. Use of the post-insertion method for the formation of ligand-coupled liposomes. Cell Mol Biol Lett. 2002;7:217–9.
42. 10.2144/00011313210.2144/000113132 ↗
43. 10.1016/j.canlet.2021.02.01110.1016/j.canlet.2021.02.011 ↗
44. Kandimalla R Aqil F Alhakeem SS Jeyabalan J Tyagi N Agrawal A Yan J Spencer W Bondada S Gupta RC. Targeted oral delivery of Paclitaxel using Colostrum-Derived exosomes. Cancers (Basel) 2021 13.10.3390/cancers13153700 ↗
45. 10.1021/acsomega.7b0188610.1021/acsomega.7b01886 ↗
46. 10.1039/c3ob41721b10.1039/c3ob41721b ↗
47. 10.1016/j.ejpb.2016.03.02310.1016/j.ejpb.2016.03.023 ↗
48. Regula P, Agress A, Rosenstreich D, Rubinstein A, Ramesh M. Adult-onset IgE-mediated cow’s milk allergy—a rare phenotype. J Allergy Clin Immunology: Global. 2023;2:100142.
49. 10.1186/s12964-020-0530-410.1186/s12964-020-0530-4 ↗
50. 10.1021/nn502807n10.1021/nn502807n ↗